Rib-X Pharmaceuticals Inc. , New Haven, Conn. Business: Infectious Date completed: 11/29/12 Type: Venture financing Raised: $18.7 million Investors: Vatera Healthcare Partners; Warburg Pincus; ABS Ventures; Vox Equity Partners Note: Rib-X raised $18.7 million in the...

After postponing its IPO in May due to market conditions, Rib-X Pharmaceuticals Inc. turned back to the private markets. The company's new cash infusion should get it to a Phase III data event for its...

Rib-X Pharmaceuticals Inc. (New Haven, Conn.) raised $18.7 million in the first tranche of a planned $67.5 million venture round led by new investor Vatera Healthcare Partners. Existing investors Warburg Pincus; ABS Ventures; and Vox...

For small companies with constrained options in the current financing environment, alternative approaches tied to royalty or revenue interests continue to be the order of the day. Last week, a trio of alternative vehicles went...